greeksoup/ stock research

CME Group (CME) FY2025 results: revenue $6.5 billion, up 6.4% on the year

CME Group Inc. (CME) reported revenue of $6.5 billion for fiscal 2025, the year ended 31 December 2025, up 6.4% on the year before. Net income was $4.1 billion, up 15.5%, and diluted earnings per share $11.16. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2026.

Revenue
$6.5 billion
+6.4% on the year
FY2018FY2025
Operating margin
64.9%
64.1% a year earlier
FY2018FY2025
Net income
$4.1 billion
+15.5% on the year
FY2018FY2025
Diluted EPS
$11.16
+15.4% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

What management said about the year

  • Full-year adjusted EPS $11.20 vs $10.26: Full-year adjusted diluted EPS was $11.20 against $10.26; GAAP diluted EPS was $11.16 against $9.67. Adjusted net income attributable to common shareholders was $4,036.7 million against $3,692.2 million.
  • Fourth-quarter volume reached 27.4 million contracts: Fourth-quarter ADV was 27.4 million contracts, up from 25.5 million a year earlier and 25.3 million in the third quarter of 2025.
  • Average rate per contract rose to $0.707: Average rate per contract was $0.707 in Q4 against $0.701 a year earlier and $0.702 in Q3. Clearing and transaction fees were $1,327.9 million against $1,232.3 million.
  • Full-year market data revenue up 13%: Full-year market data and information services revenue was $803.1 million against $710.2 million; Q4 was $208.0 million against $181.6 million.
  • Year-end cash about $4.6 billion: Cash at December 31, 2025 was about $4.6 billion, including $200 million deposited with FICC, against $3.4 billion of debt.
Read the Q4 FY2025 earnings call summary

From this 10-K

CME Group runs derivatives exchanges, a clearing house, cash trading platforms and a market data business, letting clients trade futures, options, cash and over-the-counter products. Its four derivatives exchanges are CME, CBOT, NYMEX and COMEX. Futures and options average daily volume was 28.1 million contracts in 2025, which the company reports as a record.

CME Group Inc., the 10-K for 2025

CME Group runs derivatives exchanges, a clearing house, cash trading platforms and a market data business, letting clients trade futures, options, cash and over-the-counter products. Its four derivatives exchanges are CME, CBOT, NYMEX and COMEX. Futures and options average daily volume was 28.1 million contracts in 2025, which the company reports as a record.

The derivatives exchanges

The range covers interest rates, equity indexes, foreign exchange and agricultural, energy and metals commodities, plus cryptocurrencies. The named products are SOFR, U.S. Treasury and Federal Funds in interest rates; E-mini S&P 500, E-mini Nasdaq 100 and E-mini Russell 2000 in equity indexes; euro, Japanese yen, British pound and Australian dollar in foreign exchange; corn, soybean, wheat and livestock in agriculture; WTI crude oil, natural gas and refined products in energy; gold, copper and silver in metals; and Bitcoin, Ether, Solana and XRP in cryptocurrencies.

Trading happens mainly through CME Globex, the electronic system that runs the central limit order book, along with open outcry in Chicago for SOFR options and privately negotiated transactions. CME Direct is the platform for brokers and customers arranging, executing, recording and risk-managing trades across all six major asset classes. The customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments and central banks. Membership of an exchange carries trading right protections, certain trading fee protections and membership benefit protections, and lets a customer trade specific products at lower fees. 85% of contract volume in 2025 came from trades by members.

Clearing

The clearing house, operated by CME, clears and settles exchange-traded futures and options on futures, exchange-traded swaps and over-the-counter derivatives, with CME ClearPort as the front-end system across asset classes. It serves as the counterparty to every trade, becoming the buyer to each seller and the seller to each buyer, which limits counterparty credit risk. Open positions are marked to market at least twice each business day, taking payments from clearing firms whose positions have lost value and making payments to those whose positions have gained. One firm represented 12% of clearing and transaction fees for 2025.

In December 2025 the subsidiary CME Securities Clearing received approval from the Securities and Exchange Commission to become a securities clearing agency. The company states the goal is to help market participants comply with SEC clearing requirements for U.S. Treasury transactions as of 31 December 2026 and repo transactions as of 30 June 2027, and that it expects to launch the service later in 2026.

Cash markets

BrokerTec and EBS, both run primarily on CME Globex, are the cash businesses. BrokerTec runs global electronic trading for fixed income and money market products, covering cash U.S. Treasuries, European Government Bonds, repo on EU, UK, U.S. and other international G10 governments, emerging market fixed income instruments and Supranational and Agency Bonds, as a dealer-to-dealer platform for banks and non-bank professional trading firms. In 2025 it launched BrokerTec Chicago, a second central limit order book for cash U.S. Treasuries co-located with the U.S. Treasury futures and options markets.

EBS trades global FX products across major and emerging market currencies and Spot Precious Metals. EBS Market is a central limit order book platform for spot FX, Spot Precious Metals and non-deliverable forwards. FX Spot+, launched in 2025, connects the over-the-counter spot FX market with the FX futures complex.

Data services and the cloud

The data business sells proprietary real-time and historical market data from the exchanges and the cash markets, along with derived cash markets pricing, third-party and alternative data sets and analytic tools. CME Group distributes benchmark equity and commodity indices on behalf of third parties and licenses its own benchmarks, including CME Term SOFR Reference Rates and Term €STR Reference Rates, which are administered by its UK regulated subsidiary CME Benchmark Administration Limited. It became the first derivatives marketplace to provide live market data natively on the Google Cloud, under a 10-year strategic partnership entered in 2021, and Google Cloud is developing a private cloud region and a co-location facility in Aurora, Illinois to host the trading of CME Group's futures and options markets in the cloud.

From CME Group's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 26 February 2026: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue6,5216,1305,579+6.4%
Operating income4,2303,9323,436+7.6%
Operating margin64.9%64.1%61.6%
Pre-tax income5,3304,5414,154+17.4%
Income tax1,2581,016927+23.9%
Effective tax rate23.6%22.4%22.3%
Net income4,0723,5263,226+15.5%
Net margin62.5%57.5%57.8%
Diluted EPS$11.16$9.67$8.86+15.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow4,2773,6903,454+15.9%
Capital expenditure83.594.076.4-11.2%
Free cash flow4,1943,5963,377+16.6%
Free cash flow margin64.3%58.7%60.5%
Cash from investing1,499-82.620.9
Cash from financing56,5105,076-48,339+1,013.2%
Depreciation and amortisation108115126-6.6%
Share-based compensation94.889.582.9+5.9%
Dividends paid3,9333,5843,236+9.7%
Dividend per share$5.00$10.40$8.50-51.9%
Diluted shares, weighted360m360m360m+0.1%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity28,72826,48726,738+8.5%
Short-term borrowings0.0n/a0.0
Debt3,4223,4283,425-0.2%
Operating lease liabilities237289344-17.9%
Finance lease liabilities41.750.759.4-17.8%
Other liabilities165,995107,19299,139+54.9%
Total liabilities and equity198,424137,447129,706+44.4%
Fixed assets363386410-6.1%
Goodwill10,51510,48710,495+0.3%
Intangible assets2,6112,8223,050-7.5%
Investments125113112+10.4%
Trading assets116104101+11.6%
Cash and equivalents4,4172,8922,912+52.7%
Receivables639573536+11.5%
Other assets179,639120,069112,090+49.6%
Total assets198,424137,447129,706+44.4%

10-K for the year ended 31 December 2025, filed 26 February 2026: the filing.